Cargando…
Insulin-like growth factor-I gene therapy reverses morphologic changes and reduces hyperprolactinemia in experimental rat prolactinomas
BACKGROUND: The implementation of gene therapy for the treatment of pituitary tumors emerges as a promising complement to surgery and may have distinct advantages over radiotherapy for this type of tumors. Up to now, suicide gene therapy has been the main experimental approach explored to treat expe...
Autores principales: | Console, Gloria M, Herenu, Claudia B, Camihort, Gisela A, Luna, Georgina C, Bracamonte, Maria I, Morel, Gustavo R, Goya, Rodolfo G |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2263076/ https://www.ncbi.nlm.nih.gov/pubmed/18218140 http://dx.doi.org/10.1186/1476-4598-7-13 |
Ejemplares similares
-
Menstrual Cycle Abnormalities in Patients with Prolactinoma and Drug-induced Hyperprolactinemia
por: Kulshreshtha, Bindu, et al.
Publicado: (2017) -
Diagnostic criteria of small sellar lesions with hyperprolactinemia: Prolactinoma or else
por: Cho, Anna, et al.
Publicado: (2022) -
Hyperprolactinemia Associated with Attentional Processing and Interference Control Impairments in Patients with Prolactinomas
por: Chen, Aobo, et al.
Publicado: (2022) -
PITUITARY TUMORS-01 HYPERPROLACTINEMIA AS A CLINICAL MARKER OF INVASIVE PROLACTINOMAS
por: Gankpe, Gbetoho Fortune, et al.
Publicado: (2023) -
FRI297 Hemoglobin Decline As A Signal For Hyperprolactinemia Onset Prior To Prolactinoma Diagnosis In Hypogonadal Men
por: Rudman, Yaron, et al.
Publicado: (2023)